300006 莱美药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-0.220-0.425-3.210-6.042-23.960
总资产报酬率 ROA (%)-0.156-0.300-2.297-3.310-9.829
投入资产回报率 ROIC (%)-0.187-0.360-2.799-4.112-12.272

边际利润分析
销售毛利率 (%)64.81669.33073.49871.46668.089
营业利润率 (%)0.9986.278-10.857-5.725-21.856
息税前利润/营业总收入 (%)-2.021-2.123-7.963-7.057-16.340
净利润/营业总收入 (%)0.017-1.119-8.624-8.646-21.765

收益指标分析
经营活动净收益/利润总额(%)-553.149-2,145.438151.840119.26051.999
价值变动净收益/利润总额(%)-313.0912,421.015-7.682-45.226-0.983
营业外收支净额/利润总额(%)-2.229-1,464.312-27.63133.806-0.724

偿债能力分析
流动比率 (X)2.5912.9282.4892.5900.997
速动比率 (X)2.3292.6242.2012.3530.823
资产负债率 (%)28.70126.59128.48324.41860.874
带息债务/全部投入资本 (%)12.05511.57914.8407.79046.932
股东权益/带息债务 (%)702.602735.392568.4871,157.97599.850
股东权益/负债合计 (%)243.016270.667244.128301.73661.128
利息保障倍数 (X)0.6740.841-14.654-4.432-3.049

营运能力分析
应收账款周转天数 (天)170.259131.612153.285133.152127.609
存货周转天数 (天)247.609244.692276.541233.973218.488